Exagen filed the paperwork for a $57 Million IPO on 8/23/19. The company provides diagnostics to aid in the man"agement of autoimmune diseases. Exagen will trade on NASDAQ under the symbol "XGN."
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,